Capecitabine EP Impurity E
✓
100% accuracy
of data
24/7 scientific
support
⬡
0% tolerance in
quality of product

Stock Locations

  • New Jersey, USA
  • Czech Republic, EU
  • Mumbai, India

* Stock subject to availability.

Documentation

Download MSDS

Download Sample COA

Includes: HPLC, MASS/LC-MS, 1H NMR, FT-IR, Potency, Structure Elucidation Report (SER), and additional analytical data depending on the product.

162204-30-0Capecitabine EP Impurity E

● In Stock

Catalogue No.:VL243009
CAS No.:162204-30-0
Mol. Formula:C15H22FN3O6
Mol. Weight:359.35 g/mol

Additional information on CAS 162204-30-0

Parent drug

Capecitabine

IUPAC Name

5′-Deoxy-5-fluoro-N4-(2-methylbutyloxycarbonyl)cytidine

Synonyms

Capecitabine 3-Methylbutyloxy Impurity; [1-(5-Deoxy-?-D-ribofuranosyl)-5-fluoro-1, 2-dihydro-2-oxo-4-pyrimidinyl]-carbamic Acid 3-Methylbutyl Ester; 5′-Deoxy-5-fluoro-N4-(isopentyloxycarbonyl)cytidine; Capecitabine EP Impurity E

Description

Capecitabine EP Impurity E (CAS No: 162204-30-0) Or 5?-Deoxy-5-fluoro-N4-(2-methylbutyloxycarbonyl)cytidine,Capecitabine EP Impurity E is an impurity of Capecitabine,Capecitabine is metabolised to 5-FU which in turn is a thymidylate synthase inhibitor,which is used in the treatment of metastatic breast and colorectal cancers.

Request a Quote

"*" indicates required fields

This field is for validation purposes and should be left unchanged.
Products quotation
Name
Url